Digital Microfluidic Platform to Maximize Diagnostic Tests with Low Sample Volumes from Newborns and Pediatric

Rama S Sista1, Rainer Ng1, Miriam Nuffer1

  • 1Baebies, Inc., PO Box 14403, Durham, NC 27709, USA.

Insights

Pediatric diagnostic blood testing now uses a novel microfluidic platform to perform various assays with minimal blood samples. This technology addresses iatrogenic anemia in children by providing rapid, customized results.

Area of Science:

  • Biomedical Engineering
  • Pediatric Diagnostics
  • Microfluidics

Background:

  • Pediatric patients, especially newborns, have unique physiological needs distinct from adults.
  • Current diagnostic blood testing practices in children can lead to iatrogenic anemia due to excessive blood draw volumes.
  • Existing rapid testing platforms for adults are not always optimized for pediatric clinical relevance or sample volumes.

Purpose of the Study:

  • To develop and validate a digital microfluidic platform for pediatric diagnostic testing.
  • To address the limitations of current blood testing methods in children, focusing on reduced sample volume and customized assays.
  • To enable rapid, near-patient testing with clinically relevant assays for newborns and pediatric patients.

Main Methods:

  • Development of an automated digital microfluidic platform utilizing electrowetting for precise nanoliter droplet manipulation.
  • Creation of single-use cartridges containing all necessary reagents for sample preparation and assay performance.
  • Automation of diverse assay types including biochemical, immunoassays, and molecular assays, requiring minimal user intervention.

Main Results:

  • Successful automation of over two dozen unique tests on the platform, including cell lysis, plasma preparation, and thermocycling.
  • Assays demonstrated performance comparable to standard clinical laboratory methods.
  • The platform utilizes microliter sample volumes (<50 µL), significantly reducing blood loss and enabling simultaneous testing.

Conclusions:

  • The developed digital microfluidic platform offers a viable solution for customized pediatric diagnostic testing.
  • This technology minimizes iatrogenic anemia risk in children by requiring substantially reduced sample volumes.
  • The platform provides economical, rapid, and versatile testing capabilities crucial for neonatal and pediatric care.